Abbott (ABT) Tops Q3 EPS by 8c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Abbott Labs (ABT) PT Raised to $113 at Cowen Into Q3 Results
October 19, 2020 5:48 PM EDTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $113.00 (from $105.00) while maintaining an Outperform rating ahead of Q3 results.
The analyst commented, "Ahead of ABT's 3Q report on October 21, we're raising our 2H'20 forecasts to better... More
